Back To Schedule
Wednesday, November 20 • 9:15am - 10:00am
Keynote Address- Enhancing Drug Discovery and Development Through the Application of Machine Learning

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Artificial intelligence (AI), and more specifically machine learning (ML) methods have been used in drug discovery for several decades.  However, a convergence of technologies and recent advances and breakthroughs have generated a renewed level of interest.  As with any technology, exuberance can lead to over use or misapplication.  In order to maximize the impact and avoid misuse, a clear understanding of the requirements for generating robust predictive models and their application is critical.  Choices around featurization, suitability of the data, and the algorithms themselves are important for achieving the desired outcomes.  At present, ML is having a meaningful and expanding impact across many of the drug discovery and development stages and workflows, from target identification, through preclinical optimization, and into process development and clinical investigation, and has the potential to transform the way we discover new medicines in the future.

avatar for Juan Alvarez, Merck and Co.

Juan Alvarez, Merck and Co.

AVP Computational and Structural Chemistry, Merck and Co.
Dr. Juan Alvarez is the AVP of Computational and Structural Chemistry at Merck Research Labs, leading the computational chemistry, cheminformatics, and protein structure determination groups.  Prior to Merck, Juan was at Alkermes from 2010-2017, where he established and led biologics... Read More →

Wednesday November 20, 2019 9:15am - 10:00am EST
Essex South (3rd Floor) - Westin Copley 10 Huntington Avenue, Boston, MA 02116 USA

Attendees (1)